Holen Sie sich die Stockscreener-App
270.09
0.08%
0.21
Handel nachbörslich:
270.09
Schlusskurs vom Vortag:
$269.88
Offen:
$270.25
24-Stunden-Volumen:
939.94K
Relative Volume:
0.66
Marktkapitalisierung:
$44.46B
Einnahmen:
$16.63B
Nettoeinkommen (Verlust:
$1.39B
KGV:
33.48
EPS:
8.0674
Netto-Cashflow:
$2.12B
1W Leistung:
+0.16%
1M Leistung:
+3.95%
6M Leistung:
+62.64%
1J Leistung:
+43.79%
1-Tages-Spanne:
$267.26
$272.44
1-Wochen-Bereich:
$264.88
$273.88
52-Wochen-Spanne:
$154.50
$273.88
Iqvia Holdings Inc Stock (IQV) Company Profile
Firmenname
Iqvia Holdings Inc
Sektor
Branche
Telefon
919-998-2000
Adresse
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
270.09 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
TMO
Thermo Fisher Scientific Inc
|
658.52 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.09 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
390.90 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
167.26 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-09 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-03-06 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2026-03-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-03 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-09 | Hochstufung | Jefferies | Hold → Buy |
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-13 | Eingeleitet | BTIG Research | Buy |
| 2023-11-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-03-17 | Eingeleitet | Truist | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-11-17 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-16 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-07-07 | Eingeleitet | Stephens | Equal-Weight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-12-13 | Hochstufung | CFRA | Sell → Hold |
| 2019-11-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Hochstufung | Mizuho | Neutral → Buy |
| 2019-05-28 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-18 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-09 | Eingeleitet | UBS | Buy |
| 2018-10-02 | Bestätigt | Robert W. Baird | Outperform |
| 2018-07-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Bestätigt | Stifel | Buy |
| 2018-07-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Hochstufung | Goldman | Neutral → Buy |
| 2018-03-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
IQVIA Holdings stock gains support as $2 billion notes offering underpins balance sheet - ad-hoc-news.de
IQVIA Holdings Announces $2 Billion Senior Notes Offering - The Globe and Mail
IQVIA (NYSE: IQV) Announces $2 Billion Senior Notes Offering to Refinance Existing Debt - Kalkine Media
IQVIA Holdings Stock: Is IQV Outperforming the Health Care Sector? - Yahoo Finance
IQVIA Holdings stock dips as USD 2 billion notes add to debt debate - ad-hoc-news.de
Form 8K IQVIA Holdings Inc For: 10 September By Investing.com - Investing.com Canada
IQVIA Holdings stock heads into the open after a 3.2 percent drop - ad-hoc-news.de
IQVIA Announces Pricing of Senior NotesSeptember 9, 2026 - biospace.com
IQVIA Holdings Inc. (IQV) Announces $2 Billion Senior Notes Offe - GuruFocus
IQVIA stock rises amid $2 billion senior notes offering By Investing.com - Investing.com South Africa
IQVIA Subsidiary Prices $2 Billion of 2034 Senior Notes - marketscreener.com
IQVIA prices $2.0B of 2034 senior notes at 6.375% to refinance 2026 debt - TradingView
IQVIA (NYSE: IQV) plans $2B notes sale to redeem 2026 bonds and reduce credit-line debt - Stock Titan
IQVIA Holdings Inc. Announces Pricing of $2,000,000,000 Senior Notes Due 2034 - marketscreener.com
IQVIA Announces Offering of Senior Notes - iqvia.com
IQVIA Holdings stock falls as new USD 2 billion notes offering tightens funding profile - ad-hoc-news.de
IQV Stock Quote Price and Forecast - CNN
Is IQVIA Holdings (NYSE:IQV) Ready for More Attention? - Kalkine Media
IQVIA Holdings Inc. (IQV) latest stock news and headlines - Yahoo Finance UK
IQVIA Holdings Inc (IQV) Stock Down 3.2% but Still Overvalued -- GF Score: 90/100 - GuruFocus
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IQVIA (IQV): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
IQVIA Holdings stock gains on earnings beat and higher guidance - AD HOC NEWS
IQVIA Holdings, Inc. (IQV) Stock Analysis: Strong Analyst Consensus with 3.18% Potential Upside - DirectorsTalk Interviews
IQVIA Holdings stock holds near its yearly high - ad-hoc-news.de
IQVIA (IQV) Insider James Berkshire Sells 2,668 Shares - GuruFocus
Iqvia EVP James Berkshire sells $697k in company stock By Investing.com - Investing.com Australia
IQVIA Holdings EVP James G. Berkshire Executes Stock Appreciation Rights and Sells Shares - kalkinemedia.com
Iqvia EVP James Berkshire sells $697k in company stock - Investing.com
IQVIA Holdings (NYSE: IQV) executive sells and transfers over 5,300 shares - stocktitan.net
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
IQVIA Holdings Inc. (IQV) Peer Comparison – Compare with Others - valueresearchonline.com
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster - marketscreener.com
IQV Looks 9.6% Overvalued on GF Value™ as AI-Driven Clinical Inn - GuruFocus
James G. Berkshire plans $697K IQVIA (NYSE: IQV) stock sale - stocktitan.net
HSBC Adjusts Price Target on IQVIA Holdings to $300 From $280, Maintains Buy Rating - marketscreener.com
IQVIA Holdings (IQV) Q1 2026 Earnings Call Transcript - Fortune
IQVIA Holdings (IQV) Stock Analysis: Navigating Growth In The Healthcare Sector - DirectorsTalk Interviews
How Strong Q2 Beat And Raised 2026 Guidance At IQVIA Holdings (IQV) Has Changed Its Investment Story - Yahoo Finance
IQVIA's AI tool cut diabetes screening work by 99.5% and won an award - Stock Titan
IQVIA Holdings (IQV) Rallies On AI And Data Narrative As Fair Value Stays In View - sahmcapital.com
Here's Why You Should Retain IQVIA Stock in Your Portfolio Now - Eastern Progress
IQVIA Holdings, Inc. (IQV) Stock Analysis: A Look at Strong Buy Ratings and Revenue Growth in Healthcare - DirectorsTalk Interviews
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Iqvia Holdings stock hits 52-week high at $260.32 - Investing.com
Iqvia Holdings stock hits 52-week high at $260.32 By Investing.com - Investing.com India
IQVIA Holdings | 8-K: IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance - Moomoo
IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish? - inkl
9,249 Shares in IQVIA Holdings Inc. $IQV Purchased by Wealthfront Advisers LLC - MarketBeat
IQVIA Holdings stock trades close to 52 week high as recent earnings and outlook support elevated va - Ad-hoc-news.de
Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):